Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fahreddin Palaz, M.D.

Concepts (31)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Fahreddin Palaz's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Fahreddin Palaz has written about over time.
Biosensing Techniques, 1 publications between 2021 and 2021, average publication date January 2021. Nanotubes, Carbon, 1 publications between 2021 and 2021, average publication date January 2021. Point Mutation, 1 publications between 2021 and 2021, average publication date January 2021. Molecular Diagnostic Techniques, 1 publications between 2021 and 2021, average publication date January 2021. Nucleic Acid Amplification Techniques, 1 publications between 2021 and 2021, average publication date January 2021. Early Detection of Cancer, 1 publications between 2021 and 2021, average publication date May 2021. Genetic Engineering, 2 publications between 2021 and 2023, average publication date January 2022. Neoplasms, 2 publications between 2021 and 2024, average publication date September 2022. CHO Cells, 1 publications between 2023 and 2023, average publication date February 2023. Cricetinae, 1 publications between 2023 and 2023, average publication date February 2023. Cricetulus, 1 publications between 2023 and 2023, average publication date February 2023. Muscular Dystrophy, Duchenne, 1 publications between 2023 and 2023, average publication date December 2023. Patients, 1 publications between 2023 and 2023, average publication date December 2023.

To see the data from this visualization as text, click here.
Palaz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.